Compare Endeavour Silver Corp (EXK) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs Globus Medical Inc. Class A Common Stock — how do they compare? Endeavour Silver Corp trades at $8.01 (market cap $2.32B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 4.4× Endeavour Silver Corp's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, Endeavour Silver Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 26 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| EXK | GMED | |
|---|---|---|
Market Cap | $2.32B | $10.25B |
Volume | 8,976,489 | 1,059,528 |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $96.82 |
52-Week Low | $7.07 | $58.33 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | $2.32B | $9.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $8.24, down 3.51% today amid bearish technical signals. The company shows improving fundamentals with Q1 2026 earnings beating expectations and strong revenue growth projected for 2026. Recent news highlights operational progress at Terronera and Kolpa mines, though mechanical issues at Guanacevi and past blockades present challenges. Analyst sentiment remains predominantly bullish with 78.57% buy ratings.
EXK presents a growth story with expanding production capacity but faces execution risks. The stock's valuation appears elevated with a P/E of 39.15, requiring continued operational success to justify. Near-term catalysts include Terronera mine ramp-up and silver price movements, while operational disruptions and commodity volatility remain key risks for investors.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
